Definitive Contract HHSN268201500005C

<p>This is a $29,700.00 Firm Fixed Price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Proteogenix, a for-profit manufacturer, for a phage-display VHH antibody screening service to develop in vivo gene therapy. The contract has an ultimate completion date of August 6, 2025. The contract was awarded on August 7, 2024 and does not have a set-aside designation.</p>

This is a federal contract award from the National Cancer Institute, a civilian agency, to Hemoshear Therapeutics, LLC, a small business. The contract, valued at $1,985,657.32, is for SBIR Phase II work titled &quot;Validation of the HemoShear Tumor Microenvironment System for Drug Discovery and Development.&quot; The contract is a Cost Plus Fixed Fee Definitive Contract and was awarded on September 21, 2015, with an ultimate completion date of April 30, 2019. The contract was set aside for...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...

<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...

<p>This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Boris L. Vaisman. The contract, with a ceiling value of $144,741.44, is for the procurement of professional services and has a total small business set-aside designation. The contract was awarded on February 22, 2017, with a period of performance ending on February 21, 2022.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&amp;D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...

This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...

This federal contract award, identified as HHSN268201200064C, was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to HDL Apomics LLC, a small business. The $139,291.00 Firm Fixed Price contract is for &quot;OTHER FUNCTIONS-ANTIBODY PROTEOMICS FOR MEASURING LIPOPROTEIN SUB-POPULATIONS&quot; under the SBIR TOPIC 64 PHASE 1 - NOVEL TECHNOLOGIES FOR ASSESSING LIPOPROTEIN SUB-FRACTIONS program. The contract has a total small business set-aside...

<p>This is a $298,547 firm fixed price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Hemoshear Therapeutics, LLC, a small business. The contract is for administrative support services under the Small Business Innovation Research (SBIR) Program Phase I. The contract has a completion date of September 2, 2014. This represents a previous federal contract award to Hemoshear Therapeutics, LLC, as they have also received federal grant awards.</p>